 |
 |
 |
 |
 |
 |
 |
 |
CME/CE Research Update -- Routine HIV Testing in the U.S.: What's the Holdup? David Wohl, M.D., Explains >>
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral TherapyLiver Complications in HIV-Infected Patients
- Combining Sustiva + Viread May Increase Liver Risk, Case Reports Suggest (May 9, 2008)
In aidsmap.com - Updates to Prezista (Darunavir) Tablets Labeling (March 11, 2008)
From U.S. Food and Drug Administration - Non-Alcoholic Fatty Liver Disease Is Common in HAART-Experienced Patients; Several HIV- and Antiretroviral-Related Factors May Play Role (February 6, 2008)
From The Body PRO - Immune Reconstitution May Trigger Hepatic Flares in HIV/Hepatitis B Coinfected Patients Starting HAART (February 5, 2008)
In 15th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Rapid Liver Fibrosis Occurring More Frequently Among HIV-Infected Men Newly Coinfected With Hepatitis C (February 4, 2008)
An interview with Daniel Fierer, M.D.
In 15th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - The Liver in HIV Disease (December 4, 2007)
Translating HIV research into practice.
From The Body PRO - Tipranavir/Ritonavir-Associated Hepatotoxicity Common, But Resolves Over Time (September 30, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Antiretroviral Exposure Not Associated With Liver-Related Deaths in D:A:D Cohort (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
  |